Sys2ResearchRevisiting SAGE, climbing up the MOUNTAIN“There is always a disposition in people’s minds to think that existing conditions will be permanent. When the market is down and dull, it…Jun 13, 2021Jun 13, 2021
Sys2ResearchRevisiting Novavax, a lesson in persistenceRevisiting Novavax, a lesson in persistenceJun 6, 2021Jun 6, 2021
Sys2ResearchAnnovis Biopharma, the holy grail to a multi-billion dollar market?Annovis bio demonstrates strong potential upside based on their unique method of treating Alzheimer’s.May 17, 2021May 17, 2021
Sys2ResearchMMEDF, Where’s the Moat?Mindmed on the back of the ‘shroom-boom’ and a star investor in Kevin O’Leary has grabbed headlines as the next leader in mental health…Mar 17, 2021Mar 17, 2021